Evidence map›Paper›PMID 32274081›Full record

ArticleJournal of thoracic disease2020

Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions.

Zifeng Yang, Zhiqi Zeng, Ke Wang, Sook-San Wong, Wenhua Liang, Mark Zanin, Peng Liu, Xudong Cao, Zhongqiang Gao, Zhitong Mai and 16 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 521 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
521citing papers in PubMed, 3 pooled it
47.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

521 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,494 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

461 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 3 countries.

Zifeng YangNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Zhiqi ZengNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Ke WangHengqin WhaleMed Technology Co., Ltd., Zhuhai 519000, China.
Sook-San WongNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Wenhua LiangNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Mark ZaninNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Peng LiuJinling Institute of Technology, Nanjing Innovative Data Technologies, Inc., Nanjing 210014, China.
Xudong CaoJinling Institute of Technology, Nanjing Innovative Data Technologies, Inc., Nanjing 210014, China.
Zhongqiang GaoJinling Institute of Technology, Nanjing Innovative Data Technologies, Inc., Nanjing 210014, China.
Zhitong MaiNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Jingyi LiangNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Xiaoqing LiuNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Shiyue LiNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Yimin LiNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Feng YeNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Weijie GuanNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Yifan YangTranswarp Technologies (Shanghai) Co., Ltd., Shanghai 200030, China.
Fei LiTranswarp Technologies (Shanghai) Co., Ltd., Shanghai 200030, China.
Shengmei LuoTranswarp Technologies (Shanghai) Co., Ltd., Shanghai 200030, China.
Yuqi XieNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Bin LiuKunming University of Science and Technology, Kunming 650504, China.
Zhoulang WangNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Shaobo ZhangHengqin WhaleMed Technology Co., Ltd., Zhuhai 519000, China.
Yaonan WangHengqin WhaleMed Technology Co., Ltd., Zhuhai 519000, China.
Nanshan ZhongNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
Jianxing HeNational Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
First Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CNState Key Laboratory of Respiratory Disease · CNJinling Institute of Technology · CNKunming University of Science and Technology · CNMacau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan, Hubei province, China, coincided with

methodsWe integrated population migration data before and after January 23 and most updated COVID-19 epidemiological data into the Susceptible-Exposed-Infectious-Removed (SEIR) model to derive the epidemic curve. We also used an artificial intelligence (AI) approach, trained on the 2003 SARS data, to predict the epidemic.

resultsWe found that the epidemic of China should peak by late February, showing gradual decline by end of April. A five-day delay in implementation would have increased epidemic size in mainland China three-fold. Lifting the Hubei quarantine would lead to a second epidemic peak in Hubei province in mid-March and extend the epidemic to late April, a result corroborated by the machine learning prediction.

conclusionsOur dynamic SEIR model was effective in predicting the COVID-19 epidemic peaks and sizes. The implementation of control measures on January 23 2020 was indispensable in reducing the eventual COVID-19 epidemic size.

Indexed as

Coronavirus disease 2019 (COVID-19)epidemicmodelingsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Susceptible-Exposed-Infectious-Removed (SEIR)

Identifiers

PMID32274081
PMCPMC7139011
OpenAlexW3009876049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.